Twogee Biotech Raises €2.16M Seed Round to Commercialise Circular Biomass Technology

Why It Matters

The investment validates market demand for circular biomass solutions and positions Twogee to help heavy‑industry players monetize waste streams. Accelerated adoption could reduce reliance on fossil‑based feedstocks and cut emissions across chemical supply chains.

Key Takeaways

• €2.16 M seed round closed with strategic investors.
• Platform combines enzyme screening, strain engineering, fermentation.
• Focus on converting biomass residues into sugars for bio‑chemicals.
• Licensing model targets on‑site enzyme production, cuts emissions.
• Pilot projects already validated commercial viability.

Pulse Analysis

The circular bioeconomy is gaining momentum as governments and corporations seek to decarbonize supply chains. Biomass residues—agricultural stalks, wood chips, and food‑processing waste—represent a vast, underutilized feedstock that can be transformed into high‑value chemicals. Twogee Biotech’s predictive platform tackles the technical bottlenecks by marrying rapid enzyme screening with strain engineering and optimized fermentation, delivering higher conversion efficiencies and shorter development cycles than traditional discovery methods.

Securing €2.16 million from High‑Tech Gründerfonds, Bayern Kapital and sector players such as AgriFoodTech Venture Alliance signals strong investor confidence in enzyme‑driven circular solutions. The company’s licensing model, which enables customers to produce enzymes locally, addresses two critical industry pain points: cost‑effective scale‑up and carbon emissions associated with transport. By embedding the technology at the point of use, Twogee can help manufacturers lower their carbon footprints while unlocking revenue from previously discarded streams, a proposition that aligns with ESG targets and emerging regulatory incentives.

Looking ahead, the market for second‑generation bio‑based raw materials is projected to exceed €30 billion by 2035, driven by demand for sustainable plastics, solvents and specialty chemicals. Twogee’s early‑stage pilots demonstrate commercial viability, positioning it to capture a meaningful share of this growth. As more industrial players adopt on‑site enzyme production, the competitive advantage will shift toward firms that can deliver turnkey, low‑CO₂ solutions, making Twogee’s platform a potential catalyst for broader adoption of circular chemistry across Europe and beyond.

Deal Summary

Munich‑based Twogee Biotech announced the close of a €2.16 million seed round, with investors High‑Tech Gründerfonds, Bayern Kapital, AgriFoodTech Venture Alliance and Heinz Entsorgung. The funding will support commercialisation of its enzyme platform for converting biomass residues into sustainable raw materials and accelerate pilot projects with industrial partners.